Key result
AMI links to an overall 8.6% 30-day readmission rate that declines from 2016 to 2020.
Why the study?
Acute myocardial infarction readmissions within 30 days affect patient outcomes and healthcare costs, prompting an analysis of trends in 30-day readmissions for patients discharged after an acute MI.
Observational (n=2,572,790)
Yes
p-value: p=< 0.001
30-day readmissions after acute MI declined from 2016 to 2020, though risk remains driven by increasing comorbidity burden and evolving procedural complications.
Declining 30-day readmissions after acute MI support ongoing quality initiatives; extends temporal trend data from prior registries.
Introduction Acute myocardial infarction (MI) readmissions within 30 days (30-dr) are affecting patient outcomes and healthcare costs. This study analyzed trends in 30-dr for patients discharged after an acute MI. Methods We analyzed the 2016-2020 Nationwide Readmission Database for patients aged 18 years or older with an initial admission for acute MI who were readmitted within 30 days. Variables were identified using ICD-10 codes. The primary outcome was trends in 30-dr; secondary outcomes included trends in complications, mortality, length of stay (LOS), and healthcare costs. Multivariate and descriptive bivariate analyses were conducted, with p-values <0.05 considered statistically significant. Results Among 2,572,790 acute MI index admissions, 221,910 (8.6%) were readmitted within 30 days, with a significant decline in readmission risk over the study period (p < 0.001). Mean age was 66.9 ± 13.5 years. In-hospital mortality decreased over time (OR 0.92, 95% CI 0.88-0.96; p trend < 0.01). During index admissions, vasopressor use and acute kidney injury increased, while periprocedural bleeding declined (OR 0.38, 95% CI 0.33-0.43). In multivariable Cox regression, 30-day readmission risk declined from 2017 to 2019 (HR 0.93 to 0.87) with a slight increase in 2020 (HR 0.94). Higher age (HR 1.01) and comorbidity burden (HR 1.07) were associated with increased risk, while male sex was protective (HR 0.92 [0.90-0.94]). Periprocedural circulatory complications (OR 0.30, 95% CI 0.17-0.51) and bleeding (OR as low as 0.07, 95% CI 0.03-0.17) declined, while post-procedural anemia (OR 1.16, 95% CI 1.06-1.26) and non-inflammatory pericardial effusion (OR 1.62, 95% CI 1.34-1.97) increased. Conclusion 30-dr after acute MI declined over time, but remains driven by increasing comorbidity burden and evolving procedural complication profiles, underscoring the need for targeted risk stratification and post-discharge care. This study highlights relevant data to inform targeted interventions to reduce readmissions and complications.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2026) conducted an observational in Acute myocardial infarction (n=2,572,790). Acute myocardial infarction was associated with an overall 8.6% 30-day readmission rate, with the risk of readmission declining significantly between 2016 and 2020 (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: